✦ LIBER ✦

Cost-effectiveness analysis of the first-line therapies for nicotine dependence

✍ Scribed by Jacques Cornuz; Christophe Pinget; Allison Gilbert; Fred Paccaud

Book ID: 105920849
Publisher: Springer
Year: 2003
Tongue: English
Weight: 622 KB
Volume: 59
Category: Article
ISSN: 0031-6970
DOI: 10.1007/s00228-003-0610-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1039 A cost-effectiveness analysis of ad

1039 A cost-effectiveness analysis of adjuvant therapies for resected adenocarcinoma of the rectum

✍ Jason H. Lee 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 127 KB

The cost-effectiveness of four treatment

The cost-effectiveness of four treatments for marijuana dependence

✍ Todd A. Olmstead; Jody L. Sindelar; Caroline J. Easton; Kathleen M. Carroll 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 472 KB

Methodological issues in undertaking ind

Methodological issues in undertaking independent cost-effectiveness analysis for NICE: the case of therapies for ADHD

✍ Susan C. Griffin; Helen L. A. Weatherly; Gerry A. Richardson; Mike F. Drummond 📂 Article 📅 2007 🏛 Springer 🌐 French ⚖ 156 KB

Cost-Effectiveness of Temsirolimus for F

Cost-Effectiveness of Temsirolimus for First Line Treatment of Advanced Renal Cell Carcinoma

✍ Martin Hoyle; Colin Green; Jo Thompson-Coon; Zulian Liu; Karen Welch; Tiffany Mo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

Cost-effectiveness of First-line Antiepi

Cost-effectiveness of First-line Antiepileptic Drug Treatments in the Developing World: A Population-level Analysis

✍ Dan Chisholm; WHO-CHOICE 📂 Article 📅 2005 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 110 KB

Is paclitaxel and cisplatin a cost-effec

Is paclitaxel and cisplatin a cost-effective first-line therapy for advanced ovarian carcinoma?

✍ Allan Covens; Sylvain Boucher; Kathie Roche; Moira Macdonald; Daniel Pettitt; Br 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 567 KB

## BACKGROUND. Paclitaxel and cisplatin use for the treatment of advanced ovarian carcinoma (AOC) has been shown to increase median sunrival duration. An evaluation was performed on the economic consequences of treating AOC patients with combined paclitaxel and cisplatin chemotherapy compared with